Tagged with R

Leiden University Medical Center (LUMC) Your role as Chair of the Executive Board is a mix between CEO and CMO. On a daily basis, which do you see yourself as more – the Chief Executive Officer of the hospital or the Chief Medical Officer? The choice to have a Chairman of the Executive Board with…

Organisation of Pharmaceutical Producers of India (OPPI) Our last report on India dates back to 2006, right after the Patent Law was passed. What developments have you seen happening in the industry since then? There has been a paradigm shift with the Product Patent Regime coming in place in 2005. The era from 1970 to 2005 has…

Pyridam Farma Pyridam Farma has achieved and maintained the leading position in terms of growth in the Indonesian pharmaceutical industry for two years. What strategic choices have caused Pyridam to outperform its peers? Our strategy has three pillars: marketing, human resources, and quality. Three years ago Pyridam Farma redesigned its marketing strategies,…

Cambridge Major Laboratories Europe It has now been 12 years since you co-founded ChemShop. One of the busiest, but probably most exciting moments in that period must have been the merger with CML in 2007. At that time, now global CEO Michael Major spoke of seamless integration. Was it really that easy in practice?…

Quintiles Netherlands As an expatriate executive, you seem to be fully integrated into the local community. Can you explain to our readers what brought you here to the Netherlands? The quick answer is the charm of the Dutch. Perhaps more importantly, what’s kept me here has been the opportunity to be involved…

Beurs van Berlage The Beurs van Berlage, conference centre in the heart of Amsterdam, dates back to the year 1903, and is a significant Dutch monument and unique event center that has become a famous heritage of the country. In what ways does Beurs van Berlage reflect and serve the city of Amsterdam…

Novo Nordisk Pharma Sp. z.o.o Apart from Poland being a 40 million population market, with double digit growth, Mr. Kuczynski of Pierre Fabre was telling us that the main opportunity of the Polish market lies in the many unmet, local medical needs. What are the main specificities of the Polish market in your view and…

PharmaExpert What is PharmaExpert’s role in the Polish pharmaceutical industry? The information that PharmaExpert gathers enables us to give good insight about the evolution of the pharmacists market, the evolution of the prices in the pharma landscape, and of the level of reimbursement, among others. PharmaExpert created a model of explanation…

Atlantic Healthcare Ltd A key milestone for Atlantic Healthcare was the deal with Isis Pharmaceuticals for alicaforsen in 2007. In 2008, alicaforsen acquired orphan drug status in the U.S.; in 2009, orphan status was granted in Europe. Many companies in the UK have named market access as a key challenge—but is that an…

Merck Sp. z.o.o You joined Merck in September 1996, took gradually increasing positions at Merck, from Medical Representative (1996 – 1998), to Sales and Marketing managing positions and you were ultimately appointed Managing Director Poland in January 2008. What have been the major challenges you faced in almost three years now? Merck in…

Pfizer Polska You have been appointed at the head of Pfizer Poland last December. 2010 is a hot year for the group – even very hot for some of the top management – What has been the most challenging thing for you to deal with in this first year in Poland? The…

Bayer Co. Malaysia / Bayer Healthcare Malaysi Can you give our readers an outline of Bayer’s background in Malaysia and its current organisational division? Herbert Dittmar (HD): Bayer has been in Malaysia for around fifty years. It established its first legal entity here in the early 1970s and then engaged in a number of acquisitions worldwide including…